Nirsense
1 known investors
NIRSense develops ruggedized, wireless patient monitors that measure tissue oxygen and physiological data in uncontrolled environments for hospitals, emergency departments, and military field operations. The company's Total Oximetry monitors provide non-invasive continuous monitoring for clinicians to diagnose and treat critical conditions including heart failure and cardiogenic shock.
HealthtechMedical Devices
Investors · 1
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.5M |
| U.S. Air ForceAir Force | Phase ISTTR | 2021 | $50K |
| U.S. Air ForceAir Force | Phase I | 2020 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.